DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY. et al.
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 trial) [corrected].
J Clin Oncol 2003;
21: 2237-46
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.